Adolescence & Development
Study register · detail IPD-Meta-Analyse (3 Longitudinalstudien) · Adolescence & Development · 2014

Young adult sequelae of adolescent cannabis use: an integrative analysis.

Harm GRADE High 438 citations
Samplek = 3 Studien
n = 3.765 Pat.
Durationup to the age of 30
ControlNever-users
EndpointPsychosocial developmental…
Blindingn.a.
DesignIPD-Meta-Analyse (3 Longitudinalstudien)
Key finding

Frequent cannabis use in adolescence is associated in a dose-dependent manner with far-reaching negative psychosocial consequences into young adulthood.

Summary

IPD meta-analysis (N up to 3.765); daily cannabis use before age 17: aOR 0,37 (CI 0,20–0,66) for school completion, 17,95 (CI 9,44–34,12) for cannabis dependence, 7,80 (CI 4,46–13,63) for other illicit drugs, 6,83 (CI 2,04–22,90) for suicide attempt; clear dose-response relationship for all 7 developmental outcomes.

P
PopulationAdolescents and young adults from three Australian-New Zealand longitudinal studies, n=2537–3765 (depending on outcome), cannabis use before the age of 17
I
InterventionMaximum frequency of cannabis use before the age of 17 (never, <monthly, ≥monthly, ≥weekly, daily)
C
ControlNever-users
O
OutcomeDaily cannabis use in adolescence associated with reduced likelihood of school completion (aOR 0,37; 95%-CI 0,20–0,66) and university degree completion (aOR 0,38; 95%-CI 0,22–0,66) as well as strongly increased odds for cannabis dependence (aOR 17,95), other illicit drug use (aOR 7,80) and suicide attempt (aOR 6,83) by the age of 30
Confidence in the evidence
High

The highest of four GRADE levels, the effect estimate is very reliable.

Quality profile
Sample size
Blinding
Effect size Harm
Citations / year
Authors
Silins E, Horwood LJ, Patton GC, Fergusson DM, Olsson CA, Hutchinson DM, Spry E, Toumbourou JW, Degenhardt L, Swift W, Coffey C, Tait RJ, Letcher P, Copeland J, Mattick RP, Cannabis Cohorts Research Consortium.
DOI 10.1016/s2215-0366(14)70307-4
Design: IPD-Meta-Analyse (3 Longitudinalstudien)
Share
Abstract
<h4>Background</h4>Debate continues about the consequences of adolescent cannabis use. Existing data are limited in statistical power to examine rarer outcomes and less common, heavier patterns of cannabis use than those already investigated; furthermore, evidence has a piecemeal approach to reporting of young adult sequelae. We aimed to provide a broad picture of the psychosocial sequelae of adolescent cannabis use.<h4>Methods</h4>We integrated participant-level data from three large, long-running longitudinal studies from Australia and New Zealand: the Australian Temperament Project, the Christchurch Health and Development Study, and the Victorian Adolescent Health Cohort Study. We investigated the association between the maximum frequency of cannabis use before age 17 years (never, less than monthly, monthly or more, weekly or more, or daily) and seven developmental outcomes assessed up to age 30 years (high-school completion, attainment of university degree, cannabis dependence, use of other illicit drugs, suicide attempt, depression, and welfare dependence). The number of participants varied by outcome (N=2537 to N=3765).<h4>Findings</h4>We recorded clear and consistent associations and dose-response relations between the frequency of adolescent cannabis use and all adverse young adult outcomes. After covariate adjustment, compared with individuals who had never used cannabis, those who were daily users before age 17 years had clear reductions in the odds of high-school completion (adjusted odds ratio 0·37, 95% CI 0·20-0·66) and degree attainment (0·38, 0·22-0·66), and substantially increased odds of later cannabis dependence (17·95, 9·44-34·12), use of other illicit drugs (7·80, 4·46-13·63), and suicide attempt (6·83, 2·04-22·90).<h4>Interpretation</h4>Adverse sequelae of adolescent cannabis use are wide ranging and extend into young adulthood. Prevention or delay of cannabis use in adolescence is likely to have broad health and social benefits. Efforts to reform cannabis legislation should be carefully assessed to ensure they reduce adolescent cannabis use and prevent potentially adverse developmental effects.<h4>Funding</h4>Australian Government National Health and Medical Research Council.

The impediment to action advances action. — Marcus Aurelius